Generation of distinct cell types and numbers in developing cerebral cortex is subject to regulation by extracellular factors that positively or negatively control precursor proliferation. Although signals stimulating proliferation are well described, factors halting cell cycle progression are less well defined. At the molecular level, production and association of cyclins, cyclindependent kinases (CDKs), and CDK inhibitors (CKIs) regulate cycle progression. We now report that the endogenous peptide, pituitary adenylate cyclase activating polypeptide (PACAP), negatively regulates the cell cycle by inhibiting p57
Recently, anti-mitogenic signaling in developing cortex has been defined. Pituitary adenylate cyclase activating polypeptide (PACAP) is widely expressed during neurogenesis, exhibiting population-specific inhibition (Lu and DiCicco-Bloom, 1997; DiCicco-Bloom et al., 1998 Waschek et al., 1998; Nicot and DiCicco-Bloom, 2001 ). In cortex, PACAP ligand and receptor are expressed (Tatsuno et al., 1994; Lu et al., 1998; Suh et al., 2001) as neurons are first born on E13.5 (Hicks and D'Amato, 1968; Konig et al., 1977) . In cultures and embryos, PACAP activates its G-protein-coupled receptor, eliciting cAMP in minutes and inhibition in 4 -8 hr. Furthermore, endogenous PACAP provides ongoing anti-mitogenic signaling as precursors progressively exit the cycle, functioning in an autocrine manner (Lu and DiCiccoBloom, 1997; Suh et al., 2001) . To investigate mechanisms, we defined PACAP effects on cycle machinery.
Antagonistic extracellular signals are mirrored by positive and negative intracellular regulators, coordinating cycle stages G 1 , DNA synthetic S-phase, G 2 , and mitosis. Extracellular signals act during G 1 to determine commitment to DNA synthesis and mitosis. Cycle progression is controlled by pro-mitogenic cyclindependent kinases (CDKs) complexed with regulatory cyclins, and anti-mitogenic CDK inhibitors (CKIs). CDK proteins remain constant throughout the cycle, whereas their activity is modulated by cyclin and CKI association. Although early G 1 depends on cyclin D-dependent kinases, the late G 1 /S transition critically depends on cyclin E/CDK2 complexes, which phosphorylate ret-, bind and inhibit all G 1 CDKs, especially cyclin E/CDK2, preventing G 1 /S transition . Although CIP/KIP proteins are expressed in dynamic and restricted ontogenetic patterns, only p57 is required for development (Lee et al., 1995; Matsuoka et al., 1995; Parker et al., 1995; Fero et al., 1996; Kiyokawa et al., 1996; Yan et al., 1997; Zhang et al., 1997) . Furthermore, p57 K ip2 expression colocalizes with PACAP systems in E15.5 cortex, suggesting possible interactions (van Lookeren Campagne and Gill, 1998) . We now report that PACAP inhibits precursor mitosis and CDK2 activity by selectively increasing p57 K ip2 protein and kinase association. These observations establish one mechanism whereby endogenous anti-mitogenic signals actively induce cell cycle withdrawal in cortical precursors and suggest cell lineage-specific proliferation control.
MATERIALS AND METHODS
Antibodies. Antibodies against CDK2 (SC -163), cyclin E (SC -481), p27 K ip1 (SC -528), actin (SC -1615), p57 K ip2 (SC8298; SC1039), and p21 C ip1 (SC -397) were from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal antibody against p21 C ip1 (65951A) was purchased from PharMingen (San Diego, CA). Polyclonal antibody against p57 was a gift from Dr. Pumin Z hang (Baylor College of Medicine, Houston, TX). Monoclonal antibody K P10 against p57 K ip2 was a gift from Dr. Ed Harlow (Harvard Medical School, Boston, M A). Biotin-conjugated secondary antibodies were purchased from Boehringer Mannheim (Indianapolis, I N), Santa Cruz Biotechnology, and Promega (Madison W I).
Cortical cell culture and characterization. Time-mated pregnant Sprague Dawley rats were obtained from Hilltop Labs (Philadelphia, PA). At E14.5, embryonic skull and meninges were removed and dorsolateral cerebral cortex was dissected, mechanically dissociated, and plated, at 3-4 ϫ 10 6 cells, 2 ϫ 10 6 cells, or 10 5 cells, on poly-D-lysine (1 g /ml)-coated 60 mm dishes, 35 mm dishes, or 24-multiwell plates, respectively, in defined medium (insulin omitted), as described previously (L u and DiC icco-Bloom, 1997) . Culture medium was composed of a 50:50 (v/ v) mixture of DM EM and F12 (Invitrogen, Grand Island, N Y) containing penicillin (50 U/ml) and streptomycin (50 g /ml) and supplemented with transferrin (100 g /ml) (C albiochem, La Jolla, CA), putrescine (100 M), progesterone (20 nM), selenium (30 nM), glutamine (2 mM), glucose (6 mg /ml), and bovine serum albumin (10 mg /ml). Unless stated otherwise, components were obtained from Sigma (St. L ouis, MO). Cultures were maintained in a C O 2 incubator. PACAP (American Peptide, Sunny vale, CA) or vehicle (1 mg BSA /ml PBS) was added at plating.
To characterize the phenotype of precursors that were mitotic during the 8 hr incubation period, two distinct strategies were used. The very low poly-D-lysine (1 g /ml) concentration used to enhance proliferation had the disadvantage of reducing adhesion to such an extent that precursors were lost during the multiple washes required for immunocytochemistry. Furthermore, high cell density precluded analysis of cells in clumps, especially after several days in culture, which promoted differentiation. To address these issues, cells were incubated at usual high density, 2 ϫ 10 6 cells/35 mm dish, and low adhesion conditions, in the presence of bromodeoxyuridine (BrdU; 10 M) for the entire 8 hr incubation, labeling all cells in S-phase potentially responsive to PACAP. To remove BrdU after the 8 hr, cells were lifted by gentle pipetting, pelleted at 2500 rpm for 10 min, resuspended twice in PBS, and replated in two conditions. To promote adhesion and single cell analysis, cells were plated at low density, 1-2 ϫ 10 5 /35 mm dish, on standard poly-Dlysine (100 g /ml), and incubated for 2 and 3 d before fixation. However, because these conditions may possibly lead to different outcomes than the maintenance of cell -cell contact, another group was replated under the usual high density and low adhesion conditions. Then at 2 and 3 d, cells were lifted and dissociated using a trypsin (0.05%)/ EDTA (0.5 mM)/ saline solution, exposed to trypsin inhibitor (2 mg /ml), replated at low density with standard poly-D-lysine (100 g /ml), and fixed 3 hr later for characterization by double immunocytochemistry. C ells were processed for markers of precursors, nestin (1:1000; developed by S. Hockfield, provided by Developmental Studies Hybridoma Bank, University of Iowa), neurons, ␤III tubulin (1:1000, T uJ1, clone TU-20; Biogenesis, Poole, UK), and M AP-2 (polyclonal, 1:1000; I. Fischer, Medical College of Philadelphia), astrocytes, GFAP (polyclonal, 1:1000, Chemicon AB5040; Chemicon, Temecula, CA), and oligodendrocytes, MBP (monoclonal, 1:50, MCA184S; Serotec, K idlington, Oxford, UK) and NG2 (polyclonal, 1:750, Chemicon AB5320) as described previously (Nicot and DiC icco-Bloom, 2001 ). Staining was visualized using a Vectastain ABC K it and DAB reaction (Vector, Burlingame, CA). To visualize BrdU labeling, cells were fixed again, exposed to 2N HC l (30 min), rinsed twice in PBS, incubated with monoclonal anti-BrdU (1:100; Becton-Dickinson, San Jose, CA), followed by FI TC -conjugated secondary antibody, as described previously (L u and DiC icco-Bloom, 1997; Nicot and DiC icco-Bloom, 2001 ). Approximately 100 BrdU (ϩ) cells in two to three dishes per antigen and condition were analyzed under epifluorescent microscopy and scored for expression of neural markers under bright field at both 2 and 3 d of incubation. Negative controls consisted of no primary antibody or glial and neuronal cultures for the neuronal and glial antigens, respectively. Positive controls for glia (kindly provided by C. Dreyfus, Robert Wood Johnson Medical School) were virtually pure P1 astrocytes or oligodendrocytes. Because the data at 2 and 3 d were similar, the latter data alone are reported. In addition, the percentages of cellular expression were no different under the two culture paradigms, so the data were summed and are presented in Table 1 .
DNA synthesis. Cell c ycle anal ysis. C ells were detached from plates using trypsin (0.05%)/ EDTA (0.5 mM)/saline and transferred to a polypropylene tube. A single cell suspension was made by repeated pipetting through a 1000 l pipette tip. C ells were pelleted and resuspended in 0.1 M PBS. One hundred microliters of RNase (1 mg /ml) were added to the tube and incubated for 5 min at 37°C. Next, 5 l of propidium iodide was added and incubated for an additional 5 min. at 37°C. C ells were then analyzed by a flow cytometer.
Protein e xtract preparation. C ells were detached from 60 mm culture plates using a rubber policeman in PBS, pH 7.4. C ells were pelleted and resuspended in buffer (20 mM H EPES-KOH, pH 7.5, 5 mM KC l, 0.5 mM MgC l 2 ), 0.5 mM dithiothretiol (DTT), 2 mM phenylmethylsulfonyl fluoride, 1 mM leupeptin, and 3.5 g /ml aprotinin . C ells were lysed by sonication and centrif uged to separate the pellet. Protein extracts were adjusted to 0.1 M NaC l and then stored at Ϫ80°C.
Western blotting. Protein extracts (30 -100 g per lane) were analyzed by 12% SDS-PAGE. Protein was transferred from gel to poly vinylidene difluoride (PV DF) membrane by transfer apparatus at 30 V for 4 hr. The membrane was blocked with 5% BSA or 5% milk and incubated with primary antibody against cyclin, CDK , or inhibitor. After incubation with anti-rabbit, anti-goat, or anti-mouse horseradish peroxidaseconjugated secondary antibody, protein was visualized using enhanced chemiluminescence system (Pierce, Rockford, IL).
Histone H1 k inase assay. Protein extracts (20 -40 g per sample) were incubated for 30 min at 37°C in the presence of assembly buffer containing 20 mM H EPES-KOH, pH 7.5, and 7 mM MgC l 2 , and 40 mM phosphocreatine, 0.16 mg /ml creatine phosphokinase (1:1, glycerol / H 2 O), 12 mM ATP, 2 mM DTT (Sigma), and exogenous recombinant cyclin E (gift of Moses Chao, Skirball Institute, New York University) . E xogenous cyclin E allowed better detection of kinase reaction without changing the intrinsic activity of protein extracts (Koff et al., 1993) . The assembled extracts were subjected to immunoprecipitation in 0.5% Nonidet P-40-radioimmune precipitation (N P40-RI PA) buffer (50 mM Tris, pH 7.4, 250 mM NaC l, 0.5% Nonidet P-40, 5 mM EDTA) for 1 hr at 4°C in the presence of antibody against CDK2 followed by a 1 hr incubation with immobilized protein A-Sepharose beads (Pharmacia Biotech, Piscataway, NJ). The beads were washed twice with N P40-RI PA buffer and then four times with kinase assay buffer (20 mM Tris, pH 7.4, 7.5 mM MgC l 2 , 1 mM DTT). Phosphorylation of histone H1 was performed by incubating beads in a 50 l reaction mixture containing 10 Ci of [␥- 32 P] ATP (DuPont N EN, Boston, M A), 30 M disodium ATP (Sigma), and 1 g of histone H1 (Boehringer Mannheim) at 37°C for 30 min. After incubation, the supernatants were resolved by 12% SDS-PAGE. The gel was dried and subjected to autoradiography.
Immunoprecipitation. Cortical cell lysates (200 g) were incubated on ice for 30 min with several dilutions of CDK2 primary antibody. Fifty microliters of protein A-Sepharose (Pharmacia Biotech) were added for an additional 1 hr at 4°C. Precipitates were washed five times with 900 l of 0.5% N P40-RI PA buffer before electrophoresis and Western transfer.
Densitometric anal ysis and image production. Autoradiographic films were analyzed for intensity using the Bio-Rad Gel Doc 2000 quantif ying signal with Quantity One version 4.2.1 software. Images were entered into a Macintosh Power Mac G4 computer using the UM AX PowerL ook 1100 scanner, using magic scan 4.4 program, and converted to Adobe Photoshop files using version 5.0 for composition and printing.
RESULTS

Expression of cell cycle proteins during cerebral cortical development
Previous studies have examined mRNA expression patterns of CIP/KIP family members during rodent embryogenesis (van Lookeren Campagne and Gill, 1998; Delalle et al., 1999) . p57
mRNA was detected in the VZ, the subventricular zone (SVZ), and the cortical plate (CP) of the neocortex at E15.5 and E17.5. Similarly, p27 K ip1 mRNA expression was intense in the VZ at E13.5 and in VZ and SVZ from E15.5 through E20. In contrast, p21 C ip1 mRNA was absent at E15.5 and E17.5 with exception of the ependymal layer and choroid plexus. To further characterize expression of CIP/KIP family members, we examined protein levels in fresh brain tissue extracts throughout the period of cortical neurogenesis by immunoblot. p57 K ip2 protein was expressed in rat cortex at E14.5, the earliest age examined. Protein levels increased from E14.5 to E15.5, remained constant through E18.5, and increased again by postnatal day (P) 2 (Fig. 1 ). p27
protein levels were also detected at E14.5 and exhibited a sustained increase thereafter (Fig. 1) . In contrast, we were only able to detect low levels of p21 C ip1 at E14.5, using multiple antibodies, consistent with other expression studies van Lookeren Campagne and Gill, 1998) . The progressive increase in CIP/KIP family protein expression raises the possibility of regulatory functions during neurogenesis, as cells progressively exit the cycle.
Progress through early G 1 phase depends on CDK4/6 activity, whereas activation of CDK2 is essential to pass the G 1 /S boundary and initiate DNA synthesis. We therefore examined CDK2 protein levels and kinase activity throughout development, as an index of proliferative cells. CDK2 kinase activity was intense at E14.5 and decreased to barely detectable levels by P2 (Fig. 2) , paralleling the decrease in precursor proliferation in developing cortex Takahashi et al., 1999) . Interestingly, CDK2 protein levels decreased in parallel with kinase activity; however, by P2, CDK2 protein was present without detectable activity (Fig. 2) . The absence of CDK2 activity may be expected as a result of the presence of both p57 K ip2 and p27
inhibitors, because association with the CDK2 complex (see below) is known to inhibit kinase activity . Alternative although less likely reasons for different levels of protein and kinase activity may include differential assay sensitivities or different levels of CDK2 phosphorylation, which defines catalytically active and inactive forms (Koff et al., 1993) .
PACAP decreases S-phase entry and DNA synthesis in cortical progenitor cells
In previous studies of cortical precursors in low-density culture (10 5 cells per dish), Ͼ90% of the cells expressed MAP2 and NSE by 24 hr, whereas all cells exhibited these markers by 2 d. PACAP inhibited precursor DNA synthesis without inducing cell death, acting via the cAMP pathway (Lu and DiCicco-Bloom, 1997) . Although mitotic inhibition reached a peak of 43% at 24 hr, effects were initiated rapidly, with 25% inhibition by 6 hr. Furthermore, in addition to effects of exogenous PACAP, the endogenous peptide apparently plays a neurogenetic role, because blockade of PACAP receptor activity elicited mitotic stimulation, Figure 1 . Developmental time course of p57 K ip2 and p27 K ip1 protein expression. Cell extracts were prepared from rat embryo cortices at E14.5, E15.5, E18.5, and P2 and were separated (50 g per sample) by 12% SDS-PAGE, transferred to PVDF membrane, and then incubated with antibody to p57 K ip2 (KP10 mouse monoclonal) or p27 K ip1 . Visualization was by the enhanced chemiluminescence technique. The experiment was repeated three times with identical results. p57 K ip2 and p27 K ip1 protein levels increased during development. Coomassie blue staining is shown at the bottom to demonstrate equal protein loading, because reprobing of immunoblots with actin antibody revealed developmental regulation of the cytoskeletal protein. both in culture and in vivo, consistent with an autocrine regulatory function (Lu and DiCicco-Bloom, 1997; Suh et al., 2001 ). The rapid anti-mitogenic effects of the peptide raised the possibility that G 1 cell cycle molecules were targets of PACAP receptor activation.
In the current study, we found that PACAP and its downstream signal, cAMP, increased the proportion of cells in G o /G 1 from 60 to 72%, a 20% enhancement, suggesting that peptide signaling may inhibit DNA synthesis by blocking the G 1 /S transition (Fig.  3A) . To begin examining possible peptide effects on CDK activity in vitro, we optimized previous culture conditions to promote precursor proliferation, by increasing cell density to 2-3 ϫ 10 5 cells/cm 2 and decreasing substrate adhesiveness. Using the new model, we performed analysis to define a time course of the effect of PACAP. Although PACAP elicited no inhibition during the first 4 hr, there was a 26% reduction in DNA synthesis by 6 hr, and further inhibition thereafter (Fig. 3B) . This rapid inhibition of DNA synthesis is comparable with previous 6 hr culture studies and parallels the rapid anti-mitogenic action of PACAP observed recently in living embryos (Lu and DiCicco-Bloom, 1997; Suh et al., 2001 ). Consequently, we chose an 8 hr culture paradigm to define the role of late G 1 pro-mitogenic and anti-mitogenic machinery in PACAP neurogenetic activity. However, because the changes in culture conditions potentially alter the composition of the cultures compared with previous characterization, we analyzed the neural fate of mitotic cells in this modified system. Specifically, we labeled cells that entered S-phase using BrdU for the entire 8 hr incubation, because this cohort of precursors is the target of PACAP anti-mitogenic action. Subsequently we analyzed their fate by performing double immunocytochemistry to colocalize BrdU nuclear labeling with cytoplasmic markers for neurons and glia (Table 1) . At 2 and 3 d, the overwhelming majority of cells entering S-phase during the 8 hr incubation exhibited neuronal markers: 81 and 84%, respectively, exhibited MAP2, whereas 68% expressed TuJ1. Significantly, an additional 10% expressed the precursor marker nestin. In contrast, although we detected only rare GFAP-positive cells in our cultures, 0.01% at 3 d, and no cells expressing oligodendrocyte markers, NG2 and MBP, there was no colabeling with BrdU, indicating that the culture model was composed primarily of neuronal precursors.
PACAP decreases cyclin E/CDK2 complex activity but not protein levels in cortical progenitor cells
As the transition from G 1 into S-phase depends on cyclin E/CDK2 activity, we defined PACAP effects on these promitogenic regulators. Furthermore, this kinase complex is a useful index for inhibitory action of CIP/KIP family members. Cortical cells were incubated in control or PACAP-containing medium for 8 hr, and cultures were assessed for DNA synthesis and changes in CDK2 activity. PACAP exposure inhibited DNA synthesis by 35% (Fig. 4, top) . In parallel culture extracts, we found that PACAP treatment decreased CDK2 kinase activity by ϳ75% compared with control (Fig. 4, middle) . This was a change in enzyme-specific activity, because PACAP treatment did not alter CDK2 protein levels during the 8 hr incubation. These observations suggest that the reduction in cortical precursor mitosis induced by PACAP depends in part on inhibition of this critical regulator of S-phase entry.
The stimulatory activity of CDK2 kinase depends on the its G 1 phase-specific regulatory subunit, cyclin E. Potentially, PACAP may induce rapid loss of cyclin E, the levels of which are subject to ubiquitin-dependent degradation (Singer et al., 1999; Nakayama et al., 2001 ). However, examination of cultures after 8 hr exposure to PACAP demonstrated no change in cyclin E protein levels by Western analysis (Fig. 4, bottom) , indicating that decreased levels of pro-mitogenic regulators, cyclin E and CDK2 Cortical precursors were incubated at high density (2-3 ϫ 10 5 cells/cm 2 ) in the presence of BrdU (10 M) for 8 h. After rinsing twice in defined medium, cells were replated and further incubated in the absence of BrdU until day 3, at which time cultures were fixed and analyzed by double immunocytochemistry.
protein, did not underlie PACAP anti-mitogenic activity. In turn, we evaluated potential roles of the CKIs.
PACAP selectively stimulates p57
Kip2 levels and association with CDK2
The pro-mitogenic functions of CDKs are balanced by antimitogenic regulators, including CIP/KIP inhibitors p21
, and p57 K ip2 . Thus, in parallel experiments, we examined the effects of PACAP on CKIs. Although PACAP treatment decreased CDK2 kinase activity, the peptide increased levels of p57 K ip2 protein by more than twofold (Fig. 5) . In contrast, PACAP had no effect on p27 K ip1 protein levels, and p21
protein was not detected, as observed in fresh tissue extracts. The selective increase in p57 K ip2 protein elicited by PACAP raises the possibility that it may be a specific intracellular mediator of PACAP effects. Because CKI-CDK association is a prerequisite for the regulation of kinase activity, we next examined the effect of PACAP on p57 K ip2 association with the CDK2 kinase complex. After incubating precursors in control or PACAP-containing medium, cell extracts were subjected to kinase immunoprecipitation using CDK2 antibody, and complexes were separated and examined for CDK2-associated proteins. We found increased levels of p57 K ip2 protein associated with CDK2 after PACAP treatment compared with control ( Fig. 6 A) , suggesting that p57 K ip2 interacts directly with CDK2 to inhibit cell cycle progression. Moreover, after PACAP treatment, p57 K ip2 protein unassociated with the CDK2 complex was no longer detectable in the supernatant (Fig. 6 B) . In marked contrast, the inhibitor remained unassociated with the kinase in control cells, indicating that PACAP regulated p57 K ip2 protein association in addition to total protein levels.
DISCUSSION
Our results define a mechanism whereby an endogenous antimitogenic signal regulates intrinsic cell cycle machinery in neuronal precursors to elicit cell cycle exit. PACAP induced a rapid increase in p57 K ip2 levels while decreasing CDK2 kinase activity, S-phase entry, and DNA synthesis. Furthermore, PACAP enhanced p57 K ip2 association with the kinase complex, consistent with its anti-mitogenic activity. In contrast, there were no changes in levels of CDK2, cyclin E, or CKIs p21 C ip1 and p27 K ip1 , suggesting that p57 K ip2 plays a specific role in cortical neurogenesis. Finally, a selective function of p57 K ip2 in neuronal progenitor cell cycle exit contrasts markedly with that of p27 K ip1 in glial precursors, raising the possibility that CIP/KIP members play lineage-specific roles in neural cell cycle regulation.
Mitogenic regulation in developing cerebral cortex
Although extracellular factors play major roles in proliferation control, little is known about underlying cell cycle mechanisms. Recent evidence suggests that the precise temporal schedule of proliferation and cell cycle exit reflects interaction among positive and negative extracellular signals. bFGF, EGF, and IGF-I stimulate mitogenesis in culture and in vivo, increasing neuron numbers and brain growth (Gensburger et al., 1987; Drago et al., 1991; Ghosh and Greenberg, 1995; Kilpatrick and Bartlett, 1995; Vaccarino et al., 1995 Vaccarino et al., , 1999 Burrows et al., 1997; Cavanagh et al., 1997; Qian et al., 1997; Lillien and Raphael, 2000) . The persistent expression of cortical mitogens during neurogenesis, however, raises questions regarding mechanisms by which precursors cease proliferating. Culture studies indicate that developing cortex contains anti-mitogenic signals: GABA and glutamate potentially act as paracrine signals after E15, released from cortical plate neu- 3 H]thymidine was added at 5 hr, and incorporation was assayed at 8 hr. Data are expressed as mean cpm Ϯ SEM. *p Ͻ 0.05. Middle, Using parallel cultures, extracts (30 g per sample) of control and PACAP (10 Ϫ8 M)-treated cells were analyzed for CDK2 kinase activity, using methods as in Figure 2 . PACAP decreased CDK2 activity by ϳ75%. Hela cells were used as positive control [(ϩ)CON]. Extracts were also subjected to Western blot analysis to determine whether PACAP regulated CDK2 protein levels. No change was observed in total CDK2 protein levels after PACAP treatment. Immunoblots were reprobed with actin antibody to verify equal protein loading. Experiments were performed three times yielding similar results. Bottom, Parallel extracts were analyzed for cyclin E protein levels by immunoblotting, indicating no change, a result obtained in four separate experiments.
rons to inhibit VZ precursors (LoTurco et al., 1995; Antonopoulos et al., 1997) . However, at E13.5, when preplate neurons are first generated (Hicks and D'Amato, 1968; Konig et al., 1977; Bayer and Altman, 1991) , endogenous PACAP inhibits proliferation in vitro (Lu and DiCicco-Bloom, 1997 ) and, more importantly, provides ongoing anti-mitogenic signaling in the developing embryo cortex (Suh et al., 2001) . Because PACAP counters endogenous mitogen stimulation, the evidence supports a model of interacting antagonistic extracellular signals regulating neurogenesis.
Although stimulatory and inhibitory proliferative factors are known, negative regulation of neuronal cell cycle machinery by extracellular signals has not been described previously. The mammalian cell cycle is a complex, coordinated array of steps. Under pro-mitogenic signaling, cyclin D-dependent kinases initiate retinoblastoma protein (Rb) phosphorylation in mid-G 1 , after which cyclin E/CDK2 becomes active, phosphorylating Rb at additional sites (for review, see Sherr and Roberts, 1999) . Rb hyperphosphorylation in late G 1 disrupts its association with E2F transcription factors, promoting activation of S-phase genes. Regulation at multiple steps may induce cell cycle exit. First, with- Figure 5 . Effect of PACAP on CKI protein levels. Top, Cortical precursors were incubated in control medium or medium containing PACAP (10 Ϫ8 M) for 8 hr. Cell extracts (50 g per sample) were prepared by harvesting and sonication and analyzed by Western blot. Hela cell extracts were used as positive control [(ϩ)CON]. Membranes were cut at ϳ42 kDa, and each half was incubated with p57 K ip2 or p27 K ip1 and p21
antibody as appropriate. PACAP increased p57 K ip2 protein levels more than twofold. In contrast, PACAP did not alter levels of p27 K ip1 protein. p21 C ip1 protein was barely detectable and exhibited no change with PACAP exposure (data not shown). Filters were reprobed with actin antibody or stained with Coomassie blue to verify equal protein loading (data not shown). Bottom, Histogram of relative p57 K ip2 protein levels obtained in three separate experiments, expressed as percentage of control densitometric signal. p Ͻ 0.001. Figure 6 . Effect of PACAP on CDK2 associated proteins. Cell extracts (200 g per sample) from control and PACAP-treated cortical cultures were incubated on ice for 30 min with CDK2 antibody, control antibody, or no antibody and then immunoprecipitated at 4°C for 1 hr. Precipitates and supernatants were separated on 12% SDS-PAGE and transferred to a PVDF membrane. Membranes were cut at ϳ42 kDa, and each half was incubated with p57 K ip2 or CDK2 antibody as appropriate. A, PACAP increased the amount of p57 K ip2 protein associated with CDK2 (p57 Immunoblot). Probing of immunoprecipitates with CDK2 antibody indicated that similar levels of the complex from control and PACAP-treated groups were obtained and effectively separated and transferred to filters for Western analysis. B, p57 K ip2 protein unassociated with the CDK2 complex was no longer detected in supernatant from PACAP-treated cultures, whereas residual inhibitor remained in control cell extracts. Equal loading is demonstrated by actin probing of the immunoblot.
drawal of pro-mitogenic signals halts cyclin D synthesis, leading to inactivation of cyclin D-dependent kinases and release of bound CKIs, which in turn inhibit cyclin E/CDK2 complexes and induce arrest Nagahara et al., 1999) . Second, negative signals may stimulate CKI levels, which inhibit cyclin D-dependent kinases and cyclin E/CDK2 complexes, actively inducing cell cycle exit. Because cortical mitogens are expressed throughout neurogenesis (Drago et al., 1991; Powell et al., 1991; Vaccarino et al., 1999) , presumably maintaining cyclin D levels, it is likely that additional anti-mitogenic pathways are required for cell cycle exit.
CKIs act as primary effectors of signaling pathways controlling cell cycle exit, especially CIP/KIP members, which inhibit all kinases involved with G 1 /S transition (Koff et al., 1993; Kato et al., 1994; Polyak et al., 1994a,b; Lee et al., 1995; Matsuoka et al., 1995) . For example, the anti-proliferative signals, serum withdrawal, cAMP, prostaglandins, and rapamycin, all increased synthesis and levels of p27 K ip1 by two-to fourfold in 3-15 hr, demonstrating rapid changes in inhibitor levels and interaction with CDK complexes, whereas antisense blockade of inhibitors restored cycle progression (Kato et al., 1994; Coats et al., 1996) . In the current studies, we characterized cycle components critically regulating the late G 1 /S transition. CDK2 kinase was most highly expressed and active at E14.5-15.5, when VZ cells divide symmetrically to produce additional precursors, whereas levels diminished progressively as cells exited the cycle to produce neurons Takahashi et al., 1995 Takahashi et al., , 1999 . Conversely, CIP/KIP proteins expressed in developing brain, p27 K ip1 and p57
, increased progressively with ontogeny, consistent with mRNA expression (van Lookeren Campagne and Gill, 1998; Delalle et al., 1999) , suggesting roles in mitotic withdrawal.
We found that PACAP increased p57 K ip2 expression and association with the cyclin E/CDK2 complex, reducing kinase activity. Consequently, fewer cells entered S-phase, accumulating in G 1 , which in turn resulted in decreased DNA synthesis. In contrast, PACAP did not alter levels of cyclin E, p21 C ip1 , or p27 K ip1 , suggesting that p57 K ip2 plays a selective role in withdrawal of neuronal precursors. Furthermore, these rapid changes in cycle machinery are entirely consistent with the timing of peptide effects observed previously in cultures and living embryos (Suh et al., 2001) . These studies describe the first evidence of a G 1 kinase in mammalian neuronal precursors being negatively regulated by a physiological agent.
Anti-mitogenic function for p57 has been defined previously in culture and in vivo. Unlike other CKIs, including p21 C ip1 , p27 K ip1 , p15, p18, and p16, p57 K ip2 is essential for development (Yan et al., 1997; Zhang et al., 1997) . In its absence, animals die, exhibiting proliferative disorders in multiple tissues, including lens, adrenal gland, bone, and placenta. Mitotic labeling is increased more than twofold in chondrocytes, whereas ectopic mitoses occur in lens fibers, suggesting aberrant cycling during differentiation. In the nervous system, twice as many retinal precursors undergo mitosis at E14.5 in deletion mutants, whereas p57 K ip2 overexpression elicits premature cell cycle exit (Dyer and Cepko, 2000) . Finally, p57 K ip2 likely plays additional roles in postmitotic survival and/or differentiation. For example, major p57 K ip2 expression in retina occurs from E14.5 to E20.5 as precursors exit the cycle, whereas subsequent postnatal expression suggests differentiation functions in an amacrine subpopulation (Dyer and Cepko, 2000) . Similarly, p57 K ip2 is expressed during prenatal and early postnatal cortical neurogenesis, decreasing markedly thereafter (van Lookeren Campagne and Gill, 1998; Cunningham and Roussel, 2001 ; this study). Localization of p57 K ip2 to VZ and CP suggests multiple roles in the transition from proliferation to differentiation, although functions await definition. Our current observations identify one upstream signal regulating p57 K ip2
anti-mitogenic activity during brain development.
Although our studies support an anti-mitogenic role for p57 K ip2 , understanding precise inhibitor function in ventricular zone precursors awaits cellular analysis. For example, at E14.5, progressively more neurons are born as a consequence of asymmetric precursor division, yielding one postmitotic neuron and one proliferative stem cell Takahashi et al., 1995 Takahashi et al., , 1999 . Potentially, p57 K ip2 is expressed in the mitotic precursor and subsequently distributed asymmetrically to one daughter cell to elicit withdrawal, a pattern recently described for TIS21/PC3, a protein apparently determining cell cycle exit (Iacopetti et al., 1999; Malatesta et al., 2000) . Alternatively, p57 K ip2 is downstream of TIS21 or similar regulatory signals, blocking G 1 progression and maintaining and promoting differentiation by preventing cycle reentry (Cunningham and Roussel, 2001) . In current experiments, PACAP-p57 K ip2 signaling elicited rapid inhibition of G 1 progress and DNA synthesis, consistent with the latter alternative. On the basis of intriguing overexpression studies, a similar role may be considered for p27 K ip1 , which rapidly reduced mitotic labeling 25-32% by apparently increasing G 1 length, whereas effects on neurogenesis await definition (Mitsuhashi et al., 2001) . Interestingly, manipulations of diverse extracellular factors and intrinsic cycle proteins yield similar ϳ25% changes in precursor mitosis, implicating a complex and resilient regulatory network (LoTurco et al., 1995; Antonopoulos et al., 1997; Lu and DiCicco-Bloom, 1997; Mitsuhashi et al., 2001; Nicot and DiCicco-Bloom, 2001; Suh et al., 2001) .
Although PACAP modulates p57 K ip2 function to inhibit CDK2 activity and G 1 /S transition, other cycle machinery may be involved. PACAP may act on early G 1 , cyclin D-dependent kinases, CDK4 and CDK6, by altering INK4 proteins or cyclins. Recent work indicates critical roles for early G 1 kinases in cortical precursors, in contradistinction to tumor lines (Ferguson et al., 2000) . However, because CIP/KIP proteins bind and inhibit all G1 kinases, cyclin D-dependent kinases are likely targets of elevated p57 K ip2 (Lee et al., 1995; Matsuoka et al., 1995) . Furthermore, compound deletion mutants suggest that cooperative interactions among pro-mitogenic and anti-mitogenic machinery contribute to tissue specific regulation of cell cycle withdrawal (Zindy et al., 1997 (Zindy et al., , 1999 Zhang et al., 1998 Zhang et al., , 1999 Caspary et al., 1999; Cheng et al., 1999; Gomez Lahoz et al., 1999) .
Population selectivity
Does selective p57
K ip2 regulation provide insight into cortical cellular diversity? In rat, neuronal populations are generated between E13 and E20, whereas gliogenesis proceeds postnatally. Potentially, progenitors are multipotent, the changing environment determining cell fate, including use of specific CKIs. Alternatively, cells may be intrinsically diverse as neurogenesis commences, with specific lineage dictating both CKI use and final cell fate. We found that both p27 K ip1 and p57 K ip2 were expressed at E14.5, and levels increased with development. However, the levels and CDK2 association of p57 K ip2 alone were regulated by environmental signal PACAP. Because the precursors differentiate to express MAP2, NSE, tau, and class III ␤-tubulin (Table 1) knock-out mice exhibited increased mitotic precursors of glia in embryonic spinal cord and oligodendrocytes in neonatal forebrain . Moreover, in oligodendrocyte cultures, cell cycle arrest caused by mitogen withdrawal or transmitter receptor activation increased p21 C ip1 and p27 K ip1 levels and CDK2 association Ghiani et al., 1999) , whereas p27 K ip1 deletion enhanced proliferation, suggesting that different neural lineages use distinct CKIs. However, roles for p27 K ip1 in control of neuronogenesis have been suggested (Zindy et al., 1997 (Zindy et al., , 1999 Delalle et al., 1999; Dyer and Cepko, 2001) . Thus, as an alternative, PACAP and cAMP may induce withdrawal of a precursor subpopulation (Suh et al., 2001 ) through p57 K ip2
. In contrast, factors stimulating different intracellular pathways in alternative neuronal or glial lineages may act via p27 K ip1 , an issue to address by comparing PACAP with other inhibitory signals.
In summary, the endogenous anti-mitogenic signal, PACAP, elicited rapid cell cycle exit by acting on G 1 phase progression. PACAP increased levels of p57 K ip2 and promoted its association with the CDK2 complex, reducing kinase activity. The selective response of p57 K ip2 to PACAP in neuronal progenitors suggests that lineage-specific expression and function of CKIs is involved in generating cellular diversity.
